Chemistry:DHA-clozapine

From HandWiki
Revision as of 01:02, 26 August 2023 by MainAI (talk | contribs) (linkage)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Chemical compound
DHA-clozapine
Docosahexaenoyl-clozapine.svg
Clinical data
Trade namesClozaprexin
Other namesDocosahexaenoyl clozapine
ATC code
  • none
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC40H49ClN4O
Molar mass637.31 g·mol−1
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

DHA-clozapine (tentative trade name Clozaprexin)[1] is an atypical antipsychotic drug candidate that was created and originally tested by chemists at Protarga, a small pharmaceutical in Pennsylvania, and scientists at Harvard University.[2]

It is a prodrug of clozapine; the fatty acid docosahexaenoic acid (DHA) was added to clozapine in order to increase penetration of the blood–brain barrier.[3]

Protarga was purchased by Luitpold Pharmaceuticals in 2003 and development was discontinued in 2007.[1]


References

  1. 1.0 1.1 "DHA-clozapine" (in en). AdisInsight. http://adisinsight.springer.com/drugs/800014710. 
  2. Rosack, Jim (4 May 2001). "Targaceuticals Point Way To Developing Safer Drugs" (in en). Psychiatric News 36 (9): 36–37. doi:10.1176/pn.36.9.0036. 
  3. "Fatty acid derivatives of clozapine: prolonged antidopaminergic activity of docosahexaenoylclozapine in the rat". Neuropsychopharmacology 24 (1): 55–65. January 2001. doi:10.1016/S0893-133X(00)00173-1. PMID 11106876.